It could be said quite fairly that to date it has been an interesting journey as far as shares of Kanabo (KNB) have been concerned, not least on the basis
Kanabo Group Plc (LSE:KNB), a medical cannabis R&D Company that focuses on the distribution of cannabis-derived products for medical patients, and non-THC products for CBD consumers, announces Kanabo’s CBD products
Quantum Blockchain Technologies (QBT) announced its unaudited Interim Results for the 6 months ended 30 June 2021.Over the period the company received shareholder approval to commence a new blockchain &
Xtract Resources (XTR) reminded its followers that it has more under its sleeve than Bushranger. It provided an update on the Phase 2 drilling programme at the Eureka copper-gold deposit
Huge honour to be able to play a small part in today Ride4Rahma Challenging 70-mile ride from Dewsbury to the historic city of York to raise funds for ongoing projects
The Board of Kanabo notes the recent announcement published by Materia and are delighted that Materia’s wholly-owned subsidiary Materia Deutschland GmbH (“Materia Deutschland”), has entered into an agreement with German
Zak Mir takes a technical analysis look at some of the most followed stocks on the London market. Today’s selection includes Argo Blockchain, CentralNic, GS Technologies, Kanabo, Oberon, Online Blockchain,
Serviceman takes on seven days of endurance with no rest for charity
Kanabo Group Plc (LSE: KNB), a London-based medical cannabis R&D company, announces that the Company, in partnership with Pure Origin Group, has completed its first EU-GMP production line.
Grab a coffee, settle down and listen to the guy’s view – thoughts covering this week in the markets. New and exclusive to Share Talk
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
